BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Eiras S. Nε-carboxymethyl-lysine and inflammatory cytokines, markers and mediators of coronary artery disease progression in diabetes. World J Diabetes 2024; 15(4): 575-578 [PMID: 38680703 DOI: 10.4239/wjd.v15.i4.575]
URL: https://www.wjgnet.com/1948-9358/full/v15/i4/575.htm
Number Citing Articles
1
Zhipeng Hao. Impact of inflammatory factors on coronary CT calcification score: correlation with plaque stability and evaluation of diagnostic efficiencyAmerican Journal of Translational Research 2025; 17(11) doi: 10.62347/BDUM2830
2
Qiming Gong, Yuqing Huang, Fahui Liu, Tingting Zhou, Wei Huang, Yong Xu. Trained immunity: New insights into pathogenesis and therapeutic targets in diabetes and diabetic complicationsGenes & Diseases 2026; 13(5) doi: 10.1016/j.gendis.2025.101940
3
Jiafeng Peng, Hongxing Zhang, Huaize Wang, Qianqian Meng, Danyang Li, Minglei Gao, Yingchun Li, Xingfu Ma, Li Xia, Ran Xu, Junchen Zhu. Mechanistic insights into Guizhi Fuzi decoction for lumbar disc herniation: Integrating network pharmacology and bioinformatics approachMedicine 2025; 104(12) doi: 10.1097/MD.0000000000041917
4
Cresci-Anne C. C. Croes, Marialena Chrysanthou, Tamara Hoppenbrouwers, Harry Wichers, Jaap Keijer, Huub F. J. Savelkoul, Malgorzata Teodorowicz. Diabetic Glycation of Human Serum Albumin Affects Its ImmunogenicityBiomolecules 2024; 14(12) doi: 10.3390/biom14121492
5
José Carlos Tatmatsu-Rocha, Luan Santos Mendes-Costa. Inflammatory markers, oxidative stress, and mitochondrial dynamics: Repercussions on coronary artery disease in diabetesWorld Journal of Diabetes 2024; 15(9): 1853-1857 doi: 10.4239/wjd.v15.i9.1853